Thromboembolism in Pregnancy: Gynecologists Perspective

Pregnancy is a thrombogenic condition in both antenatal and postpartum periods. Venous thromboembolism (VTE) is a common cause of morbidity, and the cause of maternal death in such situations is pulmonary embolism. There are several risk factors for thrombotic phenomena in pregnancy both acquired an...

Full description

Bibliographic Details
Main Author: Anupama Hari
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2018-08-01
Series:Indian Journal of Cardiovascular Disease in Women
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1676154
id doaj-0afaebb53c264edba3ce9498a85993ab
record_format Article
spelling doaj-0afaebb53c264edba3ce9498a85993ab2020-12-02T18:43:18ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Cardiovascular Disease in Women2455-78542018-08-010302/0308609710.1055/s-0038-1676154Thromboembolism in Pregnancy: Gynecologists PerspectiveAnupama Hari0Department of Obstetrics & Gynecology, Malla Reddy Medical College for Women, Hyderabad, Telangana, IndiaPregnancy is a thrombogenic condition in both antenatal and postpartum periods. Venous thromboembolism (VTE) is a common cause of morbidity, and the cause of maternal death in such situations is pulmonary embolism. There are several risk factors for thrombotic phenomena in pregnancy both acquired and hereditary. Accurate diagnosis of deep vein thrombosis (DVT) and its treatment are very important to prevent life-threatening pulmonary embolism. Among the diagnostic techniques, compression ultrasound is the mainstay for DVT diagnosis, whereas computed tomographic pulmonary angiography (CTPA) is for pulmonary embolism. Anticoagulants play a major role in therapy. They are used both in the active stage of thromboembolism and also in thromboprophylaxis in the postpartum period. Different types of heparins are available, which can be tailored to the individual requirements. During therapy they need monitoring to prevent hemorrhagic complications. Oral anticoagulants cannot be given in pregnancy as a general rule because of their teratogenicity, though they can be used in the postpartum period. Thrombolysis is can be taken up in selected cases in the acute situations. A very prolonged treatment of anticoagulants and compression stockings are needed in patients with past history of VTE. The most convenient drug regimen for prophylaxis is once-daily weight-adjusted low-molecular-weight heparin (LMWH). The goal of this article is to facilitate the recognition of thromboembolic disorders in pregnancy and different regimens in their management during antenatal, intrapartum, and postpartum periods. A few interesting and rare cases from the author’s experience are also presented at the end.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1676154venous thromboembolismpulmonary embolismanticoagulants in pregnancy
collection DOAJ
language English
format Article
sources DOAJ
author Anupama Hari
spellingShingle Anupama Hari
Thromboembolism in Pregnancy: Gynecologists Perspective
Indian Journal of Cardiovascular Disease in Women
venous thromboembolism
pulmonary embolism
anticoagulants in pregnancy
author_facet Anupama Hari
author_sort Anupama Hari
title Thromboembolism in Pregnancy: Gynecologists Perspective
title_short Thromboembolism in Pregnancy: Gynecologists Perspective
title_full Thromboembolism in Pregnancy: Gynecologists Perspective
title_fullStr Thromboembolism in Pregnancy: Gynecologists Perspective
title_full_unstemmed Thromboembolism in Pregnancy: Gynecologists Perspective
title_sort thromboembolism in pregnancy: gynecologists perspective
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
series Indian Journal of Cardiovascular Disease in Women
issn 2455-7854
publishDate 2018-08-01
description Pregnancy is a thrombogenic condition in both antenatal and postpartum periods. Venous thromboembolism (VTE) is a common cause of morbidity, and the cause of maternal death in such situations is pulmonary embolism. There are several risk factors for thrombotic phenomena in pregnancy both acquired and hereditary. Accurate diagnosis of deep vein thrombosis (DVT) and its treatment are very important to prevent life-threatening pulmonary embolism. Among the diagnostic techniques, compression ultrasound is the mainstay for DVT diagnosis, whereas computed tomographic pulmonary angiography (CTPA) is for pulmonary embolism. Anticoagulants play a major role in therapy. They are used both in the active stage of thromboembolism and also in thromboprophylaxis in the postpartum period. Different types of heparins are available, which can be tailored to the individual requirements. During therapy they need monitoring to prevent hemorrhagic complications. Oral anticoagulants cannot be given in pregnancy as a general rule because of their teratogenicity, though they can be used in the postpartum period. Thrombolysis is can be taken up in selected cases in the acute situations. A very prolonged treatment of anticoagulants and compression stockings are needed in patients with past history of VTE. The most convenient drug regimen for prophylaxis is once-daily weight-adjusted low-molecular-weight heparin (LMWH). The goal of this article is to facilitate the recognition of thromboembolic disorders in pregnancy and different regimens in their management during antenatal, intrapartum, and postpartum periods. A few interesting and rare cases from the author’s experience are also presented at the end.
topic venous thromboembolism
pulmonary embolism
anticoagulants in pregnancy
url http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1676154
work_keys_str_mv AT anupamahari thromboembolisminpregnancygynecologistsperspective
_version_ 1724403154539249664